Exact Mass: 486.0749

Exact Mass Matches: 486.0749

Found 33 metabolites which its exact mass value is equals to given mass value 486.0749, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

1-(8-carboxy-7-methyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)-1-deoxy-5-O-phosphono-D-ribitol

C17H19N4O11P (486.0788)

(+/-)-Ibipinabant

N-(4-Chlorobenzenesulphonyl)-3-(4-chlorophenyl)-n-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide

C23H20Cl2N4O2S (486.0684)

tjipanazole E

C24H20Cl2N2O5 (486.0749)

Mersalyl acid

C13H18HgNO6 (486.084)

C - Cardiovascular system > C03 - Diuretics > C03B - Low-ceiling diuretics, excl. thiazides > C03BC - Mercurial diuretics D004791 - Enzyme Inhibitors

(S)-SLV 319

3-(4-chlorophenyl)-N-[(4-chlorophenyl)sulfonyl]-4,5-dihydro-N-methyl-4s-phenyl-1H-pyrazole-1-carboximidamide

C23H20Cl2N4O2S (486.0684)

(±)-SLV 319

3-(4-chlorophenyl)-N-[(4-chlorophenyl)sulfonyl]-4,5-dihydro-N-methyl-4-phenyl-1H-pyrazole-1-carboximidamide

C23H20Cl2N4O2S (486.0684)

(R)-SLV 319

3-(4-chlorophenyl)-N-[(4-chlorophenyl)sulfonyl]-4,5-dihydro-N-methyl-4R-phenyl-1H-pyrazole-1-carboximidamide

C23H20Cl2N4O2S (486.0684)

9,9-(5-bromo-1,3-phenylene)bis(9H-carbazole)

C30H19BrN2 (486.0732)

2-(5-BROMO-2-TRITYLOXYPHENYL)-1 3-

C28H23BrO3 (486.083)

6-bromo-9-phenyl-3,9-Bi-9H-carbazole

C30H19BrN2 (486.0732)

Diethyloxadicarbocyanine iodide

3,3-Diethyloxadicarbocyanine iodide

C23H23IN2O2 (486.0804)

D004396 - Coloring Agents > D002232 - Carbocyanines

2-phenyl-N-[4-(2-thiazolylsulfamoyl)phenyl]-4-quinolinecarboxamide

C25H18N4O3S2 (486.082)

[2-(4-Methoxyphenyl)-2-oxoethyl] 2-[(4-hydroxy-3-nitrophenyl)sulfonylamino]benzoate

C22H18N2O9S (486.0733)

ibipinabant

C23H20Cl2N4O2S (486.0684)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D063385 - Cannabinoid Receptor Modulators D018377 - Neurotransmitter Agents > D063385 - Cannabinoid Receptor Modulators > D063387 - Cannabinoid Receptor Antagonists C78272 - Agent Affecting Nervous System > C29728 - Anorexiant

[(2R,3S,4R,5R)-5-[2-(dimethylamino)-7-methyl-6-oxo-1H-purin-9-ium-9-yl]-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate

C13H22N5O11P2+ (486.0791)

3,4,5-Trihydroxy-6-[(15-hydroxy-13-oxo-6,8,20-trioxapentacyclo[10.8.0.02,9.03,7.014,19]icosa-1,4,9,11,14,16,18-heptaen-11-yl)oxy]oxane-2-carboxylic acid

C23H18O12 (486.0798)

Exact Mass: 486.0749

Exact Mass Matches: 486.0749

1-(8-carboxy-7-methyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)-1-deoxy-5-O-phosphono-D-ribitol

(+/-)-Ibipinabant

tjipanazole E

Mersalyl acid

(2R,3R)-dihydromyricetin-4-O-(3-O-methyl)-gallate

(2R,3R)-dihydromyricetin-3-O-(3-O-methyl)-gallate

(+/-)-SLV 319

(S)-SLV 319

(±)-SLV 319

(R)-SLV 319

9,9-(5-bromo-1,3-phenylene)bis(9H-carbazole)

2-(5-BROMO-2-TRITYLOXYPHENYL)-1 3-

6-bromo-9-phenyl-3,9-Bi-9H-carbazole

Diethyloxadicarbocyanine iodide

2-phenyl-N-[4-(2-thiazolylsulfamoyl)phenyl]-4-quinolinecarboxamide

[2-(4-Methoxyphenyl)-2-oxoethyl] 2-[(4-hydroxy-3-nitrophenyl)sulfonylamino]benzoate

ibipinabant

N-[4-(2-{2-[3-(2-Bromo-acetylamino)-propionylamino]-3-hydroxy-propionylamino}-ethyl)-phenyl]-oxalamic acid

3-(4-Chlorophenyl)-N-((4-chlorophenyl)sulfonyl)-N-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide

[4-(3-Chlorophenyl)sulfonyl-3-nitrophenyl]-[4-(2-pyridinyl)-1-piperazinyl]methanone

[(2R,3S,4R,5R)-5-[2-(dimethylamino)-7-methyl-6-oxo-1H-purin-9-ium-9-yl]-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate

N-[2-[(2S,5R,6S)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]ethyl]-3,5-dichlorobenzamide

N-[2-[(2R,5S,6R)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]ethyl]-3,5-dichlorobenzamide

N-[2-[(2R,5R,6R)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]ethyl]-3,5-dichlorobenzamide

N-[2-[(2R,5S,6S)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]ethyl]-3,5-dichlorobenzamide

N-[2-[(2R,5R,6S)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]ethyl]-3,5-dichlorobenzamide

N-[2-[(2S,5S,6R)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]ethyl]-3,5-dichlorobenzamide

N-[2-[(2S,5S,6S)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]ethyl]-3,5-dichlorobenzamide

N-[2-[(2S,5R,6R)-5-(benzenesulfonamido)-6-(hydroxymethyl)-2-oxanyl]ethyl]-3,5-dichlorobenzamide

3,4,5-Trihydroxy-6-[(15-hydroxy-13-oxo-6,8,20-trioxapentacyclo[10.8.0.02,9.03,7.014,19]icosa-1,4,9,11,14,16,18-heptaen-11-yl)oxy]oxane-2-carboxylic acid

2,3-dihydroxy-5-[(2r,3r)-3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl]phenyl 3,4-dihydroxy-5-methoxybenzoate

(2r,3r,4s,5s,6r)-2-{3,8-dichloro-12h-indolo[2,3-a]carbazol-11-yl}-6-(hydroxymethyl)oxane-3,4,5-triol

2,6-dihydroxy-4-[(2r,3r)-3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl]phenyl 3,4-dihydroxy-5-methoxybenzoate